Literature DB >> 20221819

[Disseminated nocardiosis : Diagnostic challenge].

J Heyn1, A Ozimek, B Grabein, B Heindl.   

Abstract

Nocardiosis is a rarely found bacterial infection in Europe which can particularly affect immunocompromized patients. Localized infections of the dermis and lungs, as well as disseminated infections can be observed. Suspicion of nocardiosis should be reported to the microbiological laboratory so that goal-directed molecular genetic techniques and extended cultivation can be implemented for identification of the causative agent. A multitude of antibiotics can be used for successful therapy but the duration of therapy must be extended over 6-12 months. The mortality of disseminated infections ranges between 15-85% depending on the underlying immune status of the patient. The polymorphic appearance of nocardiosis is described based on the case of an intensive care patient.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20221819     DOI: 10.1007/s00101-010-1684-z

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  17 in total

Review 1.  Nocardiosis: review of clinical and laboratory experience.

Authors:  Michael A Saubolle; Den Sussland
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

2.  Nocardia species infections in a large county hospital in Miami: 6 years experience.

Authors:  José G Castro; Luis Espinoza
Journal:  J Infect       Date:  2006-09-18       Impact factor: 6.072

3.  Clinical and microbiological features of nocardiosis 1997-2003.

Authors:  J Muñoz; B Mirelis; L M Aragón; N Gutiérrez; F Sánchez; M Español; O Esparcia; M Gurguí; P Domingo; P Coll
Journal:  J Med Microbiol       Date:  2007-04       Impact factor: 2.472

Review 4.  Nocardiosis in Srinagarind Hospital, Thailand: review of 70 cases from 1996-2001.

Authors:  Piroon Mootsikapun; Benjamas Intarapoka; Waraporn Liawnoraset
Journal:  Int J Infect Dis       Date:  2005-05       Impact factor: 3.623

Review 5.  Nocardia farcinica brain abscess: a case report and review of the literature.

Authors:  H Sabuncuoğlu; Z Cibali Açikgo Z; M Caydere; H Ustün; I Semih Keskil
Journal:  Neurocirugia (Astur)       Date:  2004-12       Impact factor: 0.553

Review 6.  Actinomycoses and Nocardia pulmonary infections.

Authors:  Orhan Yildiz; Mehmet Doganay
Journal:  Curr Opin Pulm Med       Date:  2006-05       Impact factor: 3.155

Review 7.  Nocardia bacteremia. Report of 4 cases and review of the literature.

Authors:  D P Kontoyiannis; K Ruoff; D C Hooper
Journal:  Medicine (Baltimore)       Date:  1998-07       Impact factor: 1.889

8.  Clinical experience with linezolid for the treatment of nocardia infection.

Authors:  Edina H Moylett; Susan E Pacheco; Barbara A Brown-Elliott; Tracy R Perry; E Stephen Buescher; Mary C Birmingham; Jerome J Schentag; Joseph F Gimbel; Aaron Apodaca; Margot A Schwartz; Robert M Rakita; Richard J Wallace
Journal:  Clin Infect Dis       Date:  2003-01-13       Impact factor: 9.079

Review 9.  A case series and focused review of nocardiosis: clinical and microbiologic aspects.

Authors:  Edith R Lederman; Nancy F Crum
Journal:  Medicine (Baltimore)       Date:  2004-09       Impact factor: 1.889

10.  Use of imipenem in the treatment of pulmonary nocardiosis.

Authors:  W Lo; K V Rolston
Journal:  Chest       Date:  1993-03       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.